The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
Latest Information Update: 12 Dec 2024
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
Most Recent Events
- 10 Dec 2024 Status changed from recruiting to completed.
- 03 May 2023 Planned End Date changed from 5 Mar 2022 to 31 Dec 2023.
- 03 May 2023 Planned primary completion date changed from 5 Mar 2022 to 30 Oct 2023.